A VENTURE OF
PHARMACEUTICAL EXCELLENCE.

Alveon AG is a Swiss-German medtech company developing the Smart Dose Vaporisation (SDV) platform — a precision ceramic dosing technology for metered-dose inhalation of phytopharmaceuticals and plant-based active ingredients.

WHO WE ARE

A TEAM OF EXPERTS ON A MISSION.

Alveon was founded with a clear mandate: to bring pharmaceutical-grade precision to inhaled therapeutics. Our platform technology combines patented ceramic dosing mechanisms with metered-dose delivery architecture, developed by inhalation industry experts and aerospace engineers to meet the standards required for certified medical device applications.

With our Headquarters in Pfäffikon SZ, Switzerland, and our R&D Facilities near Stuttgart, Germany, we operate as a technology development and licensing company. Our first commercial application, is being developed through Alvify GmbH, a joint venture with Canify AG, for the European medical cannabis market.

MILESTONES

2020

FOUNDATION & INITIAL PROJECT FUNDING

Foundation of Alveon and initial project funding for R&D granted by the German Federal Ministry for Economic Affairs and Climate Action (BMWK) as part of the Central Innovation Programme for SMEs (ZIM).

2021

APPLICATION OF CORE PATENTS

Filing of core patents with the German Patent and Trade Mark Office (DPMA), covering evaporator design, dosing mechanism, inhaler architecture, and material properties.

MEET THE EXPERTS

As patent holder and inventor of the SDV platform, Alveon combines intensive market knowledge with expertise in aerospace engineering, product development, and pharmaceutical regulatory affairs.